IGC Pharma (IGC) Total Debt Growth (1y) (2011 - 2026)
IGC Pharma (IGC) Total Debt Growth (1y) (2011 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Total Debt Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
814,307.08 Bn |
814,307.05 Bn |
- |
- |
| 2 |
Belite Bio |
55,320.00 Bn |
55,320.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,149.72 Bn |
17,149.72 Bn |
- |
- |
| 4 |
Legend Biotech |
3,590.00 Bn |
3,589.71 Bn |
242.10 Mn |
5.94% |
| 5 |
Akari Therapeutics |
1,650.72 Bn |
1,650.72 Bn |
- |
- |
| 6 |
Evaxion A |
1,522.09 Bn |
1,522.07 Bn |
- |
- |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.09 Bn |
105.85 Bn |
2.59 Bn |
- |
| 9 |
Abivax |
90.15 Bn |
90.15 Bn |
- |
- |
| 10 |
IGC Pharma |
27.49 Mn |
27.22 Mn |
- |
62.69% |
| Date | Value |
|---|
| Mar 31, 2026 |
62.69% |
| Dec 31, 2025 |
266.42% |
| Sep 30, 2025 |
-2.22% |
| Jun 30, 2025 |
-2.21% |
| Mar 31, 2025 |
-2.19% |
| Dec 31, 2024 |
-2.90% |
| Sep 30, 2024 |
-2.88% |
| Jun 30, 2024 |
-2.86% |
| Mar 31, 2024 |
-2.84% |
| Dec 31, 2023 |
-2.13% |
| Sep 30, 2023 |
-2.11% |
| Jun 30, 2023 |
-4.11% |
| Mar 31, 2023 |
-4.08% |
| Dec 31, 2022 |
-4.73% |
| Sep 30, 2022 |
-4.70% |
| Jun 30, 2022 |
-2.67% |
| Mar 31, 2022 |
-74.66% |
| Dec 31, 2021 |
-74.48% |
| Sep 30, 2021 |
-74.31% |
| Jun 30, 2021 |
-76.19% |
